DBV Technologies DBVT
NASDAQ DBVT
$9.67 +0.19 (+2.01%)
As of: Oct 21, 2026 · 2:39 PM EDT

DBV Technologies (DBVT) Construction in Progress (2026)

Updated

DBV Technologies (DBVT) reported Construction in Progress of $3.9 million for Q1 2026.

Analysis

DBV Technologies (DBVT) Construction in Progress (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Construction in Progress (Qtr)
1 Eli Lilly 1,136.90 Bn 1,105.48 Bn 19.71 Bn -
2 Johnson & Johnson 617.06 Bn 535.59 Bn 17.26 Bn -
3 AbbVie 501.38 Bn 474.49 Bn 12.70 Bn -
4 Merck 367.41 Bn 321.79 Bn 12.21 Bn -
5 Novartis Ag 297.92 Bn 261.91 Bn 11.24 Bn -
6 Astrazeneca 261.31 Bn 235.00 Bn 12.86 Bn -
7 Amgen 236.29 Bn 191.69 Bn 7.24 Bn -
8 Gilead Sciences 190.40 Bn 164.60 Bn 6.22 Bn -
9 Pfizer 169.55 Bn 116.19 Bn 10.94 Bn -
10 DBV Technologies 837.59 Mn 169.45 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 3.90 Mn
API Access

DBV Technologies Construction in Progress API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=construction-in-progress&ticker=DBVT&period=max&api_key=YOUR_API_KEY